The SARS-CoV-2 spike protein induces lung cancer migration and invasion in a TLR2-dependent manner

Cancer Commun (Lond). 2024 Feb;44(2):273-277. doi: 10.1002/cac2.12485. Epub 2023 Sep 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Humans
  • Lung Neoplasms*
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus
  • Toll-Like Receptor 2

Substances

  • spike protein, SARS-CoV-2
  • Spike Glycoprotein, Coronavirus
  • Toll-Like Receptor 2
  • TLR2 protein, human